Clinical trials have shown that GLP-1 receptor agonists can reduce liver fat content, improve liver enzyme levels, and potentially slow the progression of liver fibrosis
However, overexpression of Pfkfb3 activates glycolysis in neurons through the APC/C-Cdh1 pathway, which inhibits the pentose phosphate pathway (PPP), reduces the oxidation of glucose-6-phosphate (G6P), decreases the production of reduced glutathione, and finally leads to oxidative stress and apoptosis (Herrero-Mendez et al., 2009)
Step 2: provider review A licensed provider reviews your submission
Miwa (2020) reported that 1,500 mg/day reduced nocturnal leg cramps post-stroke [7][55]
But knowing when to stop or seek help is essential for safe use
Calculating the number needed to treat for trials where the outcome is time to an event